Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
159.36
-2.36 (-1.46%)
Streaming Delayed Price
Updated: 2:04 PM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,996,873
Open
162.17
Bid (Size)
159.33 (1)
Ask (Size)
159.39 (2)
Prev. Close
161.72
Today's Range
158.12 - 162.44
52wk Range
130.96 - 182.89
Shares Outstanding
N/A
Dividend Yield
3.71%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
7 Safe Haven Stocks That Can Withstand the Market’s Worst Meltdowns
April 30, 2024
Safe haven stocks offer stability even during market fall in communication, financials, healthcare, energy and consumer staples.
Via
InvestorPlace
Analyst Sentiment, Revenue Growth Will Lead AbbVie Stock Higher
April 30, 2024
After falling nearly 6% based on concerns about Humira sales, AbbVie stock is recovering, and bullish analyst sentiment is likely to push the stock higher
Via
MarketBeat
Performance
YTD
-0.29%
-0.29%
1 Month
-11.84%
-11.84%
3 Month
-3.07%
-3.07%
6 Month
+11.86%
+11.86%
1 Year
+5.10%
+5.10%
More News
Read More
Inflation-Proof Fortunes: 7 Dividend Aristocrats to Keep Your Wealth Growing
April 30, 2024
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
AbbVie Outlook: Why Humira Biosimilars Won't Undo A Projected $73 Billion In Sales
April 29, 2024
Via
Investor's Business Daily
Peeling Back The Layers: Exploring AbbVie Through Analyst Insights
April 29, 2024
Via
Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
AbbVie's Options Frenzy: What You Need to Know
April 23, 2024
Via
Benzinga
Better Dividend Stock: AbbVie or Johnson & Johnson?
April 28, 2024
Via
The Motley Fool
3 Dividend Stocks to Buy and Hold for the Next Decade
April 27, 2024
Via
The Motley Fool
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
April 26, 2024
Via
The Motley Fool
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
April 26, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost
April 26, 2024
Via
Benzinga
Tech Stocks Rebound As Magnificent 7 Roar On Strong Earnings, Energy Giants Tumble: What's Driving Markets Friday?
April 26, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q1 2024
April 26, 2024
Via
InvestorPlace
Ex-Humira Growth Platform Drives AbbVie's Q1 Performance, Drugmaker Lifts Annual Profit Outlook
April 26, 2024
Via
Benzinga
AbbVie Beats First-Quarter Views As Skyrizi Looks To Take Humira's Title
April 26, 2024
Via
Investor's Business Daily
Wall Street Futures Ride High On Microsoft, Alphabet Cheer, But Will Inflation Data Burst The Bubble? Why This Analyst Thinks Bull Run Isn't Over Yet
April 26, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
April 25, 2024
Via
Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
April 25, 2024
Via
InvestorPlace
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
April 23, 2024
Via
InvestorPlace
Buying the Dip in These 3 Undervalued Dividend Stocks
April 22, 2024
Via
The Motley Fool
3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip
April 22, 2024
Via
InvestorPlace
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
April 21, 2024
Via
Benzinga
Why I Keep Buying This Ultra-High-Yielding ETF for Passive Income
April 20, 2024
Via
The Motley Fool
Topics
ETFs
These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?
April 19, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.